Long-term outcomes with nonmyeloablative HLA-identical related HCT using tacrolimus and MMF for GVHD prophylaxis

Nonmyeloablative allogeneic hematopoietic cell transplantation (HCT) from HLA-identical related donors using cyclosporine (CSP) and mycophenolate mofetil (MMF) for post-grafting immunosuppression is effective therapy for hematologic cancers. However, graft-vs-host-disease (GVHD) remains a major caus...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplant Cell Ther
Main Authors: Oshima, Masumi Ueda, Storer, Barry E., Qiu, Huiying, Chauncey, Thomas, Asch, Julie, Boyer, Michael W., Giaccone, Luisa, Flowers, Mary, Mielcarek, Marco, Storb, Rainer, Maloney, David G, Sandmaier, Brenda M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8035484/
https://ncbi.nlm.nih.gov/pubmed/33830025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtct.2020.10.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados